Basic Search  |  Summaries  |  Advanced Search

Violation Tracker Individual Record

Company: Merck
Current Parent Company: Merck
Penalty: $41,500,000
Year: 2010
Date: February 9, 2010
Offense Group: safety-related offenses
Primary Offense: drug or medical equipment safety violation
Secondary Offense: product safety violation
Mega-Scandal: Pharmaceutical Hazards
Violation Description: Merck and Schering-Plough, which subsequently merged, agreed to pay $41.5 million to settle litigation alleging they concealed an unfavorable study of the effectiveness of their cholesterol drug Vytorin.
Level of Government: federal
Action Type: private litigation
Court: District of New Jersey
Civil or Criminal Case: civil
Case ID: 2:08cv285
Case Name: In Re Vytorin/Zetia Marketing Sales Practices and Products Liability
Private Lawsuit Resolution Type: settlement
HQ Country of Current Parent: USA
HQ State of Current Parent: New Jersey
Ownership Structure of Current Parent: publicly traded
Major Industry of Current Parent: pharmaceuticals
Specific Industry of Current Parent: pharmaceuticals
Source of Data: (click here)
Link to PACER Case Docket (must be logged in): (click here)
Link to Archived Court Document:  subscribe to see this data field
Source Notes: If an online information source is not working, check the Violation Tracker Data Sources page for an updated link.
Current parent company note: Parent-subsidiary relationship is current as of the most recent revision listed in the Update Log.